Trial intelligence / Profile preview

Probiotics as Adjuvant Therapy in Metastatic Colorectal Cancer

NCT03705442Phase 2Unknown

Start
Feb 2018
Primary completion
Feb 2020
Countries
1
01

Overview

Phase 2, randomised, double-blind trial (2 arms). Primary endpoint: Incidence of grade III/IV diarrhoea between the two groups of patients at 3 months. Status: unknown.

Beyond the preview

Go deeper on NCT03705442.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03705442.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call